Skip to content

A Study on Causes and Development of Psoriasis in Patients with Analysis of Stool Findings

Etiopathological study on kitibha kustha with special reference to Psoriasis and stool examination - SSE

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/03/106981
Enrollment
60
Registered
2026-03-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L409- Psoriasis, unspecified

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

Rufshana Yasmin
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients aged between 30 to 50 years of either gender (male or female). 2. Patients clinically diagnosed with Kitibha Kustha based on classical Ayurvedic features such as: Shyava (blackish/dark discoloration), Khara Sparsha (rough texture), Pariutsanna (elevated/raised lesions), Ghana (hard/thick plaques) 3. Patients willing to give written informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Patients below 30 years or above 50 years of age. 2. Patients suffering from systemic diseases such as Diabetes Mellitus, Hypertension, Thyroid disorders, or other serious medical conditions. 3. Patients diagnosed with other types of Kustha or skin disorders not classified as Kitibha Kustha. 4. Patients who are currently undergoing any other treatment (Ayurvedic, Allopathic, or Homeopathic) for the same condition. 5. Pregnant and lactating women. 6. Patients with known drug allergies or hypersensitivity to the study drugs. 7. Patients with a history of severe psychiatric illness or non-cooperative behavior. 8. Patients with immunocompromised conditions (e.g., HIV, malignancy, long-term steroid use).

Design outcomes

Primary

MeasureTime frame
Assessment of etiopathological factors in patients of Kitibha Kustha (Psoriasis) through clinical evaluation and stool examinationTimepoint: The outcome will be assessed at Baseline

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactRufshana Yasmin

Government Ayurvedic College Hospital

yasminrufshana445@gmail.com8724939924

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026